anmeldenNASDAQ Composite Index
26.370,89
PKT
-31,53
PKT
-0,12
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu NASDAQ Composite Index-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 30.08.12 | Geron buy | Stifel, Nicolaus & Co., Inc. | |
| 30.08.12 | Gilead Sciences buy | UBS AG | |
| 30.08.12 | Teva Pharmaceutical Industries buy | UBS AG | |
| 30.08.12 | Logitech outperform | Exane-BNP Paribas SA | |
| 30.08.12 | Apple outperform | Pacific Crest Securities Inc. | |
| 30.08.12 | Volvo (B) buy | Société Générale Group S.A. (SG) | |
| 30.08.12 | Vertex Pharmaceuticals outperform | RBC Capital Markets | |
| 30.08.12 | F5 Networks buy | Deutsche Bank Securities | |
| 30.08.12 | Intel buy | Deutsche Bank Securities | |
| 29.08.12 | JAKKS Pacific buy | Needham & Company, LLC | |
| 29.08.12 | Apple buy | Banc of America Securities-Merrill Lynch | |
| 29.08.12 | SKF Group (B, Fria) outperform | Exane-BNP Paribas SA | |
| 29.08.12 | Apple buy | Jefferies & Company Inc. | |
| 29.08.12 | Schnitzer Steel Industries neutral | D.A. Davidson & Co. | |
| 29.08.12 | Gilead Sciences outperform | RBC Capital Markets | |
| 29.08.12 | Regeneron Pharmaceuticals outperform | RBC Capital Markets | |
| 29.08.12 | Intel buy | Citigroup Corp. | |
| 29.08.12 | Gilead Sciences hold | Jefferies & Company Inc. | |
| 29.08.12 | Amazon buy | Banc of America Securities-Merrill Lynch | |
| 29.08.12 | Applied Materials hold | Deutsche Bank Securities | |
| 28.08.12 | Gilead Sciences buy | Stifel, Nicolaus & Co., Inc. | |
| 28.08.12 | Alphabet A (ex Google) buy | Banc of America Securities-Merrill Lynch | |
| 28.08.12 | QUALCOMM neutral | Nomura | |
| 28.08.12 | NVIDIA buy | Nomura | |
| 28.08.12 | Apple outperform | Raymond James Financial, Inc. | |
| 28.08.12 | Alphabet A (ex Google) outperform | Robert W. Baird & Co. Incorporated | |
| 28.08.12 | Apple outperform | Sanford C. Bernstein and Co., Inc. | |
| 28.08.12 | Biogen outperform | RBC Capital Markets | |
| 28.08.12 | Anglo American equal-weight | Morgan Stanley | |
| 28.08.12 | Apple outperform | RBC Capital Markets | |
| 28.08.12 | Universal Display buy | Goldman Sachs Group Inc. | |
| 28.08.12 | Apple outperform | Oppenheimer & Co. Inc. | |
| 28.08.12 | Biomarin Pharmaceutical hold | Deutsche Bank Securities | |
| 28.08.12 | CIENA buy | Needham & Company, LLC | |
| 28.08.12 | Autodesk buy | Jefferies & Company Inc. | |
| 27.08.12 | Apple overweight | Piper Jaffray & Co. | |
| 27.08.12 | CIENA outperform | RBC Capital Markets | |
| 27.08.12 | ImmunoGen outperform | RBC Capital Markets | |
| 27.08.12 | Alphabet A (ex Google) overweight | JP Morgan Chase & Co. | |
| 27.08.12 | Apple outperform | Robert W. Baird & Co. Incorporated |
